333 related articles for article (PubMed ID: 30829023)
1. Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy.
Gülkaş S; Şahin Ö
Turk J Ophthalmol; 2019 Feb; 49(1):30-39. PubMed ID: 30829023
[TBL] [Abstract][Full Text] [Related]
2. Central Serous Chorioretinopathy Treatments: A Mini Review.
Iacono P; Battaglia Parodi M; Falcomatà B; Bandello F
Ophthalmic Res; 2015; 55(2):76-83. PubMed ID: 26619293
[TBL] [Abstract][Full Text] [Related]
3. Central serous chorioretinopathy: what we have learnt so far.
Wong KH; Lau KP; Chhablani J; Tao Y; Li Q; Wong IY
Acta Ophthalmol; 2016 Jun; 94(4):321-5. PubMed ID: 26132864
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments.
Iacono P; Toto L; Costanzo E; Varano M; Parravano MC
Curr Pharm Des; 2018; 24(41):4864-4873. PubMed ID: 30674250
[TBL] [Abstract][Full Text] [Related]
5. Oral medications for central serous chorioretinopathy: a literature review.
Fusi-Rubiano W; Saedon H; Patel V; Yang YC
Eye (Lond); 2020 May; 34(5):809-824. PubMed ID: 31527760
[TBL] [Abstract][Full Text] [Related]
6. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence.
Bousquet E; Zhao M; Daruich A; Behar-Cohen F
Exp Eye Res; 2019 Oct; 187():107754. PubMed ID: 31401003
[TBL] [Abstract][Full Text] [Related]
8. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.
Breukink MB; Downes SM; Querques G; van Dijk EHC; den Hollander AI; Blanco-Garavito R; Keunen JEE; Souied EH; MacLaren RE; Hoyng CB; Fauser S; Boon CJF
Trials; 2015 Sep; 16():419. PubMed ID: 26390920
[TBL] [Abstract][Full Text] [Related]
9. EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Feenstra HMA; Hahn LC; van Rijssen TJ; Tsonaka R; Breukink MB; Keunen JEE; Peters PJH; Dijkman G; Souied EH; MacLaren RE; Querques G; Downes SM; Fauser S; Hoyng CB; van Dijk EHC; Boon CJF
Retina; 2022 Apr; 42(4):721-729. PubMed ID: 34864802
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.
Uzlu D; Erdöl H; Kola M; Özbay AD
Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.
Willcox A; Culliford L; Ellis L; Rogers CA; Cree A; Chakravarthy U; Ennis S; Behar-Cohen F; Reeves BC; Sivaprasad S; Lotery A
Eye (Lond); 2019 Feb; 33(2):295-303. PubMed ID: 30194380
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Smretschnig E; Hagen S; Glittenberg C; Ristl R; Krebs I; Binder S; Ansari-Shahrezaei S
Eye (Lond); 2016 Jun; 30(6):805-11. PubMed ID: 26965012
[TBL] [Abstract][Full Text] [Related]
13. Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.
Sartini F; Figus M; Nardi M; Casini G; Posarelli C
Eye (Lond); 2019 Jul; 33(7):1035-1043. PubMed ID: 30824822
[TBL] [Abstract][Full Text] [Related]
14. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VERSUS PHOTODYNAMIC THERAPY IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO CENTRAL SEROUS CHORIORETINOPATHY.
Peiretti E; Caminiti G; Serra R; Querques L; Pertile R; Querques G
Retina; 2018 Aug; 38(8):1526-1532. PubMed ID: 28699928
[TBL] [Abstract][Full Text] [Related]
15. Central serous chorioretinopathy: An evidence-based treatment guideline.
Feenstra HMA; van Dijk EHC; Cheung CMG; Ohno-Matsui K; Lai TYY; Koizumi H; Larsen M; Querques G; Downes SM; Yzer S; Breazzano MP; Subhi Y; Tadayoni R; Priglinger SG; Pauleikhoff LJB; Lange CAK; Loewenstein A; Diederen RMH; Schlingemann RO; Hoyng CB; Chhablani JK; Holz FG; Sivaprasad S; Lotery AJ; Yannuzzi LA; Freund KB; Boon CJF
Prog Retin Eye Res; 2024 Jul; 101():101236. PubMed ID: 38301969
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy.
Karagiannis D; Parikakis E; Kontomichos L; Batsos G; Chatziralli I
Semin Ophthalmol; 2019; 34(6):436-441. PubMed ID: 31309849
[No Abstract] [Full Text] [Related]
17. Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials.
Wang SK; Sun P; Tandias RM; Seto BK; Arroyo JG
Ophthalmol Retina; 2019 Feb; 3(2):154-160. PubMed ID: 31014765
[TBL] [Abstract][Full Text] [Related]
18. Central serous chorioretinopathy: Towards an evidence-based treatment guideline.
van Rijssen TJ; van Dijk EHC; Yzer S; Ohno-Matsui K; Keunen JEE; Schlingemann RO; Sivaprasad S; Querques G; Downes SM; Fauser S; Hoyng CB; Piccolino FC; Chhablani JK; Lai TYY; Lotery AJ; Larsen M; Holz FG; Freund KB; Yannuzzi LA; Boon CJF
Prog Retin Eye Res; 2019 Nov; 73():100770. PubMed ID: 31319157
[TBL] [Abstract][Full Text] [Related]
19. Central Serous Chorioretinopathy - an Overview.
Berger L; Bühler V; Yzer S
Klin Monbl Augenheilkd; 2021 Sep; 238(9):971-979. PubMed ID: 34416788
[TBL] [Abstract][Full Text] [Related]
20. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
Roca JA; Wu L; Fromow-Guerra J; Rodríguez FJ; Berrocal MH; Rojas S; Lima LH; Gallego-Pinazo R; Chhablani J; Arevalo JF; Lozano-Rechy D; Serrano M
Br J Ophthalmol; 2018 Dec; 102(12):1696-1700. PubMed ID: 29439089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
